Digital Academy
| Preview | Title | Date | Type | |
|---|---|---|---|---|
 |
Locana - Industry Updates On Drug Development (2018 MDF Annual Conference) |
Ranjan Batra, PhD, Locana, provides an update on their drug development efforts in the DM field. |
5/16/19 | video |
 |
Expansion Therapeutics - Industry Updates On Drug Development (2018 MDF Annual Conference) |
Representatives from biotech and pharma companies will provide updates on their drug development efforts in the DM field. Matthew Disney, PhD, Expansion Therapeutics |
5/15/19 | video |
 |
AMO Pharma Ltd. - Industry Updates On Drug Development (2018 MDF Annual Conference) |
Joseph P. Horrigan, MD, from AMO Pharma Ltd. provides an update on their drug development efforts in the DM field. |
5/15/19 | webinar |
 |
Dr. Dixon - Strategies For Managing Progression (2018 MDF Annual Conference) |
Current strategies for managing disease progression and maintaining quality of life, including the latest in tools and resources with Missy Dixon, PhD, University of Utah. |
5/15/19 | video |
 |
Living with DM: Patients Report on Changes Over Time (2018 MDF Annual Conference) |
This interactive panel session was presented in a similar format to the Patient-Focused Drug Development meeting presented by MDF as a part of the 2016 MDF Annual Conference, and the CNS Endpoint Development discussion presented at the 2017 MDF Annual Conference. |
5/16/19 | video |
 |
Accelerating The Search For Therapies: What's Happening, What's Next (2018 MDF Annual Conference) |
Dr. Elizabeth Ackermann reports on the results of the 3-year MDF and Wyck Foundation-funded drug development acceleration effort, MDF 3.0, and introduces MDF’s new initiative, MDF 4.0, including the $1M gene editing project, the Myotonic Dystrophy Clinical Research Network study and other aggressive therapy development programs. |
5/15/19 | video |
